一致Ｂ：2021年年度报告（英文版）.PDF

1、China National Accord Medicines Corporation Ltd.Annual Report 2021March 20221Section I.Important Notice,Contents and InterpretationBoard of Directors,Supervisory Committee,all directors,supervisors and seniorexecutives of China National Accord Medicines Corporation Ltd.(hereinafterreferred to as the

2、 Company)hereby confirm that there are no any fictitiousstatements,misleading statements,or important omissions carried in this report,and shall take all responsibilities,individual and/or joint,for the reality,accuracy and completion of the whole contents.Lin Zhaoxiong,Principal of the Company,Gu G

3、uolin,person in charger ofaccounting works and Wang Ying,person in charge of accounting organ(accounting principal)hereby confirm that the Financial Report of 2021 AnnualReport is authentic,accurate and complete.All directors are attended the Board Meeting for report deliberation.The profit distribu

4、tion plan that deliberated and approved by the Board is:based on total stock issued 428,126,983 shares,distributed 6.00Yuan(taxincluded)bonus in cash for every 10-share hold by all shareholders,0 sharesbonus issued(tax included)and no capitalizing of common reserves carried out.2ContentsSction I Imp

5、ortant Notice,Contents and Interpretation.1Section II Company Profile and Main Financial Indexes.5Section III Management Discussion and Analysis.10Section IV Corporate Governance.错误！未定义书签。错误！未定义书签。Section V Enviornmental and Social Responsibility.错误！未定义书签。错误！未定义书签。Section VI Important Events.83Secti

6、on VII Changes in shares and particular about shareholders.错误！未定义书签。错误！未定义书签。9Section VIII Preferred Stock.错误！未定义书签。错误！未定义书签。9Section IX Bonds.错误！未定义书签。错误！未定义书签。0Section X Financial Report.错误！未定义书签。错误！未定义书签。13DocumentsAvailable for ReferenceI.The financial statements carried with the signature and s